摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,6-Diaminohexanoic acid;hydron

中文名称
——
中文别名
——
英文名称
2,6-Diaminohexanoic acid;hydron
英文别名
——
2,6-Diaminohexanoic acid;hydron化学式
CAS
——
化学式
C6H15N2O2+
mdl
——
分子量
147.2
InChiKey
KDXKERNSBIXSRK-UHFFFAOYSA-O
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -3
  • 重原子数:
    10
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.83
  • 拓扑面积:
    91
  • 氢给体数:
    3
  • 氢受体数:
    3

文献信息

  • NOVEL COMPLEX SALTS OF PHOSPHORIC AND AMINO ACIDS AND RUMINANT FEED ADDITIVE COMPOSITION CONTAINING THE SAME
    申请人:Ajinomoto Co., Inc.
    公开号:EP0744396A1
    公开(公告)日:1996-11-27
    A novel phosphoric acid-amino acid complex salt is provided which manifests insolubility in a neutral or alkaline aqueous solution and solubility in an acidic aqueous solution and has a basic amino acid, an alkaline earth metal, and phosphoric acid as main components thereof. An additive composition containing the complex salt and used in a feed for ruminant mammals excels in protection in the first compartment of the stomach of a ruminant mammal and solubility in the fourth compartment of the stomach. This additive composition improves the nutrition of the feed with respect to such a basic amino acid as lysine, a substance frequently missing in the feed for ruminant mammals.
    本发明提供了一种新型磷酸-氨基酸复盐,它在中性或碱性溶液中不溶解,在酸性溶液中可溶解,其主要成分为碱性氨基酸、碱土属和磷酸。含有该复合盐的添加剂组合物用于反刍哺乳动物的饲料中,在反刍哺乳动物胃的第一区段中具有出色的保护作用,在胃的第四区段中具有出色的溶解性。这种添加剂组合物改善了饲料中赖酸这种基本氨基酸的营养,而赖酸是反刍哺乳动物饲料中经常缺少的物质。
  • Aggregate crystals of phosphoric acid/lysine/magnesium composite salt and process for producing the same
    申请人:Ajinomoto Co., Inc.
    公开号:EP0826662A1
    公开(公告)日:1998-03-04
    Subject    A process for producing a phosphoric acid/lysine/magnesium salt which is excellent in slurry properties and which can industrially be produced. Means for Solution    Lysine, phosphoric acid and magnesium hydroxide or magnesium oxide are added simultaneously to a slurry containing a desired phosphoric acid/lysine/magnesium composite salt while the slurry temperature is maintained at 50 C or higher and the pH constantly in an alkaline region respectively, whereby spherical aggregate crystals are formed which were not obtained by the conventional process. Since the aggregate crystals having the uniform shape and size are formed, the slurry properties are markedly improved.
    主题 一种生产磷酸/赖酸/盐的工艺,该工艺具有优异的浆液性能,并可工业化生产。 解决方案 将赖酸、磷酸氢氧化镁氧化镁同时加入到含有所需的磷酸/赖酸/复合盐的浆料中,同时将浆料的温度分别保持在 50 摄氏度或更高,pH 值保持在碱性区域,从而形成球形聚合晶体,这是传统工艺无法获得的。由于形成了形状和大小一致的聚合晶体,浆料的性能得到了明显改善。
  • COSMETIC BASES AND COSMETICS CONTAINING THE SAME
    申请人:NOF CORPORATION
    公开号:EP1797859A1
    公开(公告)日:2007-06-20
    A basic agent for use in cosmetics comprising an alkylene oxide derivative represented by the following formula (I) is provided:         Z-O(AO)l(EO)m - (BO)nH}a     (I) (where Z represents a residue of a compound having 3 to 9 hydroxyl groups with the hydroxyl groups removed, a is from 3 to 9, AO represents an oxyalkylene group of 3 to 4 carbon atoms, EO represents oxyethylene group, l and m represent average additional mol numbers of the oxyalkylene groups of 3 to 4 carbon atoms and the oxyethylene groups, respectively, and 1 ≦1 ≦50, 1 ≦ m ≦50, the weight ratio (AO/EO) of AO to EO is from 1/5 to 5/1, AO and EO may be added in a random form or may be added in a block form. BO represents oxyalkylene group with a number of carbon atoms of 4, and n is an average additional mol number and 0.5 ≦ n ≦ 5).
    本发明提供了一种用于化妆品的基础剂,该基础剂由下式 (I) 所代表的环氧亚 烷衍生物组成: Z-O(AO)l(EO)m - (BO)nH}a (I) (其中 Z 代表具有 3 至 9 个羟基的化合物的残余物,去掉羟基,a 为 3 至 9,AO 代表 3 至 4 个碳原子的氧亚烷基,EO 代表氧乙烯基、l和m分别代表3至4个碳原子的氧亚烷基和氧乙烯基的平均附加摩尔数,1 ≦1 ≦50,1 ≦ m ≦50,AO与EO的重量比(AO/EO)为1/5至5/1,AO和EO可以无规形式添加,也可以块状添加。BO 代表碳原子数为 4 的氧亚烷基,n 为平均附加摩尔数,0.5 ≦ n ≦ 5)。
  • POLYMERIZABLE COMPOSITION FOR OPHTHALMIC AND MEDICAL USE AND ANTIBACTERIAL COMPOSITION OBTAINED BY POLYMERIZING SAME
    申请人:Nanyang Technological University
    公开号:EP2578244A1
    公开(公告)日:2013-04-10
    An object of the present invention is to provide a polymerizable composition capable of providing antimicrobial properties to ophthalmic and medical devices relatively inexpensively with ease, and an antimicrobial composition obtained by polymerizing the polymerizable composition. A polymerizable composition for ophthalmic or medical use comprising an epsilon-polylysine having (meth)acryloyl group is provided. The content of the epsilon-polylysine having (meth)acryloyl group in the polymerizable composition is preferably about 0.1 to 99% by weight, based on the whole amount of the composition. A coating agent for ophthalmic or medical use comprising the above polymerizable composition, an antimicrobial composition for ophthalmic or medical use obtained by polymerizing the above polymerizable composition, an ophthalmic or medical device comprising the antimicrobial composition, and a contact lens comprising the antimicrobial composition are also provided.
    本发明的目的是提供一种可聚合组合物,该组合物能够以相对低廉的价格轻松地为眼科和医疗设备提供抗菌特性,并提供一种通过聚合该可聚合组合物而获得的抗菌组合物。 本发明提供了一种用于眼科或医疗用途的可聚合组合物,该组合物包含一种具有(甲基)丙烯酰基的ε-聚赖酸。在可聚合组合物中,具有(甲基)丙烯酰基的ε-聚赖酸的含量按组合物总量计算,优选约为 0.1 至 99%(重量百分比)。还提供了包含上述可聚合组合物的眼科或医疗用涂层剂、通过聚合上述可聚合组合物获得的眼科或医疗用抗菌组合物、包含该抗菌组合物的眼科或医疗设备以及包含该抗菌组合物的隐形眼镜。
  • NOVEL DRUGGABLE REGIONS IN SET DOMAIN PROTEINS AND METHODS OF USING THE SAME
    申请人:EMORY UNIVERSITY
    公开号:EP1578363A2
    公开(公告)日:2005-09-28
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
cnmr
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸